Trial Profile
A randomized, controlled, double blind, double dummy clinical trial to evaluate the safety and efficacy of Loxoprofen Sodium Cataplasm Ointment (Loxonin PAP 100mg) against knee osteoarthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2013
Price :
$35
*
At a glance
- Drugs Loxoprofen (Primary) ; Loxoprofen (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Acronyms SELSOAKO
- 14 Jan 2013 New trial record